Social risk factors in patients with cystic fibrosis: impacts on exacerbations, lung function, and BMI
Therapeutic Advances in Respiratory Disease · 2025
DOI: 10.1177/17534666251393070 ↗Kurz gefasst
Fachartikel in der Zeitschrift Therapeutic Advances in Respiratory Disease, 2025. Verfasst von Zhuoyi Galvin Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: University of Tennessee Health Science Center College of Medicine, 920 Madison Ave., Memphis, TN 38163, USA. Hauptthemen laut MEDLINE: Cystic Fibrosis, Body Mass Index, Lung, Social Determinants of Health. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Cystic Fibrosis Foundation.
Abstract (Originalsprache)
Background
Cystic fibrosis (CF) outcomes are influenced by a myriad of genetic, microbiological, and environmental factors, as well as socioeconomic constraints. Studies have shown that low socioeconomic status is associated with a higher risk of death, lower body weight and height, worsened pulmonary function, and increased pulmonary exacerbation in children with CF. Screening for social risk factors (SRFs) is one possible approach to help mitigate unmet social needs in people with CF (PwCF).
Objectives
Does a positive screening response for SRF correlate with health outcomes in PwCF?
Design
This is a single-center, retrospective analysis of outcomes in adult PwCF. The study includes data from 2021 to 2022.
Methods
A social needs screening tool was administered to identify SRF in PwCF in eight domains: housing, food, transportation, utilities, healthcare cost, medication cost, income/employment, and education. A total of 121 PwCF were included in the analysis. Linear mixed-effects models, Poisson regression, and mixed-effects Cox regression were used for analyses of multivariate models.
Results
When adjusted for multiple covariables, PwCF who screened positive for SRF had similar lung function and BMI as PwCF who reported no SRF and an increased CF exacerbation rates per person/per year when compared to their peers, 1.700 (1.275, 2.266) versus 0.829 (0.608, 1.130) ( p = 0.006). Adjusted models showed that the median time to exacerbation was significantly lower in PwCF who screened positive for SRF (210 days vs 389 days).
Conclusion
PwCF who responded positively for SRF experienced an increased rate of CF exacerbation, and this finding remained significant when adjusted for multiple variables, including new CF medications. Medication cost, income/employment concerns, and food insecurity emerged as the most significant predictors of exacerbation rates and time to the next exacerbation. Further studies are needed to evaluate effective interventions and resources to mitigate SRF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University of Tennessee Health Science Center College of Medicine, 920 Madison Ave., Memphis, TN 38163, USA.
- Department of Medicine, University of Virginia, Charlottesville, VA, USA.
- University of Virginia School of Medicine, Charlottesville, VA, USA.
ORCID-Profile: Zhuoyi Galvin Li, Lindsay Somerville, Dana P Albon
Förderung
- Cystic Fibrosis Foundation
Zitieren
APA
Li, Z. G., Jennings, D., Somerville, L., Suresh, S., List, R., Lonabaugh, K., Mercante, M., Wilburn, K., Wiggins, A., Smith, A., Barros, A., & Albon, D. P. (2025). Social risk factors in patients with cystic fibrosis: impacts on exacerbations, lung function, and BMI. Therapeutic Advances in Respiratory Disease. https://doi.org/10.1177/17534666251393070
Vancouver
Li ZG, Jennings D, Somerville L, Suresh S, List R, Lonabaugh K, et al. Social risk factors in patients with cystic fibrosis: impacts on exacerbations, lung function, and BMI. Therapeutic Advances in Respiratory Disease. 2025. doi:10.1177/17534666251393070
BibTeX
@article{Li2025,
author = {Li, Zhuoyi Galvin and Jennings, Deirdre and Somerville, Lindsay and Suresh, Sriyaa and List, Rhonda and Lonabaugh, Kevin and Mercante, Margaret and Wilburn, Kasey and Wiggins, Alexis and Smith, Aaron and Barros, Andrew and Albon, Dana P},
title = {Social risk factors in patients with cystic fibrosis: impacts on exacerbations, lung function, and BMI},
journal = {Therapeutic Advances in Respiratory Disease},
year = {2025},
doi = {10.1177/17534666251393070}
}
EUVIMED